Statistics for Pembrolizumab in Combination with Neoadjuvant Chemoradiotherapy for Patients with Resectable Adenocarcinoma of the Gastroesophageal Junction

Total visits

views
Pembrolizumab in Combination with Neoadjuvant Chemoradiotherapy for Patients with Resectable Adenocarcinoma of the Gastroesophageal Junction 14

Total visits per month

views
February 2025 0
March 2025 0
April 2025 0
May 2025 0
June 2025 0
July 2025 0
August 2025 0

File Visits

views
Pembrolizumab in Combination with Neoadjuvant.pdf 38

Top country views

views
Chile 14

Top city views

views
Santiago 14